Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
figitumumab (CP-751,871)
i
Other names:
CP-751,871, CP751,871
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Novartis, Pfizer
Drug class:
IGF-1R inhibitor
Related drugs:
‹
BMS-754807 (10)
AMG 479 (10)
ASP7487 (7)
AZD3463 (2)
GSK 1838705A (2)
SY-707 (1)
BMS-536924 (0)
FPI-1434 (0)
IGV-001 (0)
KW-2450 (0)
LX-101 (0)
NVP-ADW742 (0)
NVP-AEW541 (0)
NVP-TAE226 (0)
teprotumumab-trbw (0)
XL228 (0)
IMC A12 (0)
MK 0646 (0)
MEDI-573 (0)
MM-141 (0)
AXL1717 (0)
SCH 717454 (0)
BMS-754807 (10)
AMG 479 (10)
ASP7487 (7)
AZD3463 (2)
GSK 1838705A (2)
SY-707 (1)
BMS-536924 (0)
FPI-1434 (0)
IGV-001 (0)
KW-2450 (0)
LX-101 (0)
NVP-ADW742 (0)
NVP-AEW541 (0)
NVP-TAE226 (0)
teprotumumab-trbw (0)
XL228 (0)
IMC A12 (0)
MK 0646 (0)
MEDI-573 (0)
MM-141 (0)
AXL1717 (0)
SCH 717454 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
IGF1 elevation
Ewing Sarcoma
IGF1 elevation
Ewing Sarcoma
CP-751,871
Sensitive: C3 – Early Trials
CP-751,871
Sensitive
:
C3
CP-751,871
Sensitive: C3 – Early Trials
CP-751,871
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login